Moderna says its COVID-19 vaccine candidate is 94.5% effective

Published November 16, 2020 54 Views

Rumble A COVID-19 vaccine candidate being produced by biotech company Moderna has shown to be 94.5% effective in Phase 3 clinical trials, the company said Monday.